Shawn Sterling Terry, PA-C

Shawn Terry practices at The University of Texas MD Anderson Cancer Center in Houston, Texas, part of The University of Texas System.

Shawn Terry's NPI, 1366777591, was assigned on October 6, 2009. Shawn Terry holds Texas license PA06409.

Shawn Terry's primary practice is The University of Texas MD Anderson Cancer Center, at 1515 Holcombe Blvd, Houston, TX 77030.

Shawn Terry's primary practice is The University of Texas MD Anderson Cancer Center in Houston, Texas, part of The University of Texas System. The medical group on file is Physicians Referral Service.

Dmand AI tracks the electronic health record (EHR) system at each site where Shawn Terry practices. Vendor and product names are available with a free account.

Physician assistant is Shawn Terry's primary specialty in the NPI Registry, under taxonomy code 363A00000X. Shawn Terry is board certified in certified physician assistant by the National Commission on Certification of Physician Assistants (NCCPA). Shawn Terry is licensed in Texas.

Dmand AI lists fluid and electrolyte imbalances, larynx and vocal cord disease, swimmer's ear, tobacco use and upper respiratory infection (URI) among the conditions Shawn Terry treats.

CMS data shows 375 Medicare services from Shawn Terry across 3 procedure codes in 2024, for 321 Medicare patients. Medicare paid $19,081 for them.

CMS counts 321 Medicare patients who saw Shawn Terry in 2024. The largest group is 65 to 74, with 158 patients. 75% of them have high cholesterol, and 74% have high blood pressure. Their average risk score is 1.55, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Shawn Terry's median patient age at 73, with 30% women.

In 2024, Shawn Terry wrote 324 Medicare Part D claims for 108 patients. 82% of them were for generic drugs. CMS names the drug for 204 of them, across 9 drugs with 11 or more claims each, at $5,979 in total drug cost.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 84 out of 100 for Shawn Terry for performance year 2024, reported as part of a group. Shawn Terry accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

CMS Open Payments shows 1 general payment to Shawn Terry from 1 drug or device company in 2024. Food and beverage make up the largest share, 100% of the total. Revance Therapeutics, Inc. paid the most, $36.